🇺🇸 Avalyn Pharma Inc.
Forum topic · AVLN · Company page: financials, ownership and filings
Join the discussion on Avalyn Pharma Inc.
Loading…
Results announced on 12 November 2026
Avalyn Pharma Inc. announced results on 12 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: a net loss of $30 million.
Mutual funds: 103 funds hold $247 million
103 mutual funds in 1 country hold shares of Avalyn Pharma Inc. worth $247 million, about 13.3% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 103 funds added shares and 0 sold; on balance they bought $247 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.